|
|
|
|
LEADER |
04013nam a22002895i 4500 |
001 |
000285332 |
005 |
20210902183221.0 |
007 |
cr nn 008mamaa |
008 |
170813s2017 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781493971961
|
024 |
7 |
|
|a 10.1007/978-1-4939-7196-1
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Hemostasis and Thrombosis :
|b Methods and Protocols /
|c edited by Emmanuel J. Favaloro, Giuseppe Lippi.
|
250 |
|
|
|a 1st ed. 2017.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Humana,
|c 2017.
|
300 |
|
|
|a XV, 565 p. 93 illus., 49 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Methods in Molecular Biology,
|v 1646
|
505 |
0 |
|
|a Overview of Hemostasis and Thrombosis and Contribution of Laboratory Testing to Diagnosis and Management of Hemostasis and Thrombosis Disorders -- Preanalytical Issues in Hemostasis and Thrombosis Testing -- The Interface between Immunotransfusion and Hemostasis and Thrombosis Testing -- Optimizing the Verification of Mean Normal Prothrombin Time (MNPT) and International Sensitivity Index (ISI) for Accurate Conversion of Prothrombin Time (PT) to International Normalized Ratio (INR) -- Performance of Activated Partial Thromboplastin Time (APTT): Determining Reagent Sensitivity to Factor Deficiencies, Heparin, and Lupus Anticoagulants -- Performance and Interpretation of Mixing Tests in Coagulation -- D-Dimer Testing: Laboratory Aspects and Current Issues -- Determination of Fibrinogen and Thrombin Time (TT) -- An Overview of Thrombophilia and Associated Laboratory Testing -- Laboratory Testing for Activated Protein C Resistance (APCR) -- Assessment of Hereditary Thrombophilia: Performance of Protein C (PC) Testing -- Assessment of Hereditary Thrombophilia: Performance of Protein S (PS) Testing -- Assessment of Hereditary Thrombophilia: Performance of Antithrombin (AT) Testing -- Lupus Anticoagulant Testing: Diluted Russell Viper Venom Time (dRVVT) -- Lupus Anticoagulant Testing: Activated Partial Thromboplastin Time (APTT) and Silica Clotting Time (SCT) -- Solid Phase Immunoassay for the Detection of Anticardiolipin Antibodies -- Solid Phase Immunoassay for the Detection of Anti-β2 Glycoprotein I Antibodies -- Measuring Direct Oral Anticoagulants -- Laboratory Testing Protocols for Heparin-Induced Thrombocytopenia (HIT) Testing -- One-Stage Factor VIII Assays -- Chromogenic Factor VIII Assays for Improved Diagnosis of Hemophilia A -- Assessment of Factor XIII -- Detection and Measurement of Factor Inhibitors -- Platelet Function Tests: Preanalytical Variables, Clinical Utility, Advantages and Disadvantages -- Platelet Function Analyzed by Light Transmission Aggregometry -- Whole Blood Platelet Aggregometry -- Assessment of Platelet Function in Whole Blood by Flow Cytometry -- Flow Cytometry Protocols for Assessment of Platelet Function in Whole Blood -- Diagnosis or Exclusion of Von Willebrand Disease Using Laboratory Testing -- Laboratory Testing for Von Willebrand Factor Antigen (VWF:Ag) -- Laboratory Testing for Von Willebrand Factor Collagen Binding (VWF:CB) -- Laboratory Testing for Von Willebrand Factor Ristocetin Cofactor (VWF:RCo) -- Laboratory Testing for Von Willebrand Factor Activity by Glycoprotein Ib Binding Assays (VWF:GPIb) -- Laboratory Testing for Von Willebrand Factor Factor VIII Binding (for 2N VWD) -- Ristocetin-Induced Platelet Aggregation (RIPA) and RIPA Mixing Studies -- Laboratory Testing for Von Willebrand Factor Multimers -- Thrombin Generation Assays (TGA) -- The Overall Haemostatic Potential (OHP) Assay -- Thromboelastography (TEG) -- Post-Analytical Issues in Hemostasis and Thrombosis Testing.
|
650 |
|
0 |
|a Molecular biology.
|
650 |
1 |
4 |
|a Molecular Medicine.
|
700 |
1 |
|
|a Favaloro, Emmanuel J.
|e editor.
|
700 |
1 |
|
|a Lippi, Giuseppe.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|